| Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials JY Wu, YW Tsai, WH Hsu, TH Liu, PY Huang, MH Chuang, MY Liu, ... Critical Care 27 (1), 274, 2023 | 32 | 2023 |
| The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients TH Liu, JY Wu, PY Huang, YW Tsai, CC Lai The Journal of Infection 86 (3), 256, 2023 | 21 | 2023 |
| Long‐term risk of herpes zoster following COVID‐19: a retrospective cohort study of 2 442 686 patients YC Chen, CH Ho, TH Liu, JY Wu, PY Huang, YW Tsai, CC Lai Journal of Medical Virology 95 (4), e28745, 2023 | 20 | 2023 |
| Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors WH Hsu, YW Tsai, JY Wu, TH Liu, CC Lai Journal of Infection 86 (4), e107-e110, 2023 | 15 | 2023 |
| The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network YW Tsai, CF Tsai, JY Wu, PY Huang, TH Liu, CC Lai Journal of Infection 86 (3), 256-308, 2023 | 15 | 2023 |
| Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection MH Chuang, JY Wu, TH Liu, WH Hsu, YW Tsai, PY Huang, CC Lai Journal of Medical Virology 95 (4), e28750, 2023 | 14 | 2023 |
| Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials PY Huang, TH Liu, JY Wu, YW Tsai, CC Lai Journal of Medical Virology 95 (3), e28621, 2023 | 13 | 2023 |
| Clinical effectiveness of oral antiviral agents in older patients with COVID‐19 based on real‐world data YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, CC Lai, ... Journal of medical virology 95 (6), e28869, 2023 | 12 | 2023 |
| Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19 JY Wu, MY Liu, TH Liu, MH Chuang, WH Hsu, PY Huang, YW Tsai, ... Journal of Medical Virology 95 (6), e28866, 2023 | 12 | 2023 |
| Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu, YW Tsai, CC Chang, ... Journal of Medical Virology 95 (5), e28801, 2023 | 9 | 2023 |
| Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19 JY Wu, MY Liu, TH Liu, MH Chuang, WH Hsu, PY Huang, YW Tsai, ... International Journal of Antimicrobial Agents 62 (6), 106984, 2023 | 8 | 2023 |
| Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study TH Liu, MH Chuang, JY Wu, PY Huang, YW Tsai, WH Hsu, CC Lai Journal of Medical Virology 95 (8), e28992, 2023 | 6 | 2023 |
| The association between corticosteroids and aspergillosis among COVID-19 patients YH Chang, TH Liu, JY Wu, CC Lai Journal of Infection 86 (4), 394-396, 2023 | 6 | 2023 |
| Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis WH Hsu, BW Shiau, TH Liu, JY Wu, YW Tsai, PY Huang, MH Chuang, ... Expert Review of Anti-infective Therapy 21 (10), 1143-1151, 2023 | 5 | 2023 |
| Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials JY Wu, PY Huang, TH Liu, CY Kuo, YW Tsai, HJ Tang, CC Lai Expert Review of Anti-infective Therapy 21 (6), 667-674, 2023 | 5 | 2023 |
| The effect of molnupiravir on post-acute outcome of COVID-19 survivors WH Hsu, BW Shiau, YW Tsai, JY Wu, TH Liu, MH Chuang, CC Lai The Journal of Infection, 2023 | 4 | 2023 |
| A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation KC Hung, JY Chen, SC Wu, PY Huang, JY Wu, TH Liu, CC Liu, IW Chen, ... Frontiers in Pharmacology 14, 1225288, 2023 | 4 | 2023 |
| The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19 TH Liu, JY Wu, PY Huang, YW Tsai, CC Lai Journal of Medical Virology 95 (7), e28951, 2023 | 4 | 2023 |
| Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases TH Liu, JY Wu, PY Huang, WH Hsu, MH Chuang, YW Tsai, CC Lai, ... Expert Review of Anti-infective Therapy 22 (1-3), 121-128, 2024 | 3 | 2024 |
| Post-COVID-19 condition risk in patients with intellectual and developmental disabilities: a retrospective cohort study involving 36,308 patients TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu, YW Tsai, PH Kao, ... BMC medicine 21 (1), 505, 2023 | 3 | 2023 |
Jheng-Yan WuDepartment of Nutrition, Chi Mei Medical Center, Tainan, Taiwan在 mail.chimei.org.tw 的电子邮件经过验证
